Bio-Rad Laboratories (BIO) News Today $246.78 -1.88 (-0.76%) As of 05/20/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Nomura Holdings Inc. Acquires New Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Nomura Holdings Inc. bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,055 shares of the medical research comMay 21 at 5:04 AM | marketbeat.comBio-Rad Laboratories Q1 Earnings TranscriptMay 20 at 7:21 AM | marketbeat.comSelect Equity Group L.P. Has $151.33 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Select Equity Group L.P. lowered its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 35.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 460,658 shares of the medical research company's stock after selMay 19 at 6:44 AM | marketbeat.comJefferies Financial Group Inc. Trims Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Jefferies Financial Group Inc. reduced its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 74.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,807 shares of the meMay 19 at 4:34 AM | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) is Southeastern Asset Management Inc. TN's 8th Largest PositionSoutheastern Asset Management Inc. TN lowered its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 308,469 shares of the medical research companMay 18 at 6:56 AM | marketbeat.comD. E. Shaw & Co. Inc. Grows Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)D. E. Shaw & Co. Inc. lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 46.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,625 shares of the medical research company's stock aMay 18 at 4:08 AM | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Point72 Asset Management L.P.Point72 Asset Management L.P. lessened its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 1.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 247,510 shares of the medical research company's stock after selling 2,598 shares during the quarter.May 17, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Gotham Asset Management LLCGotham Asset Management LLC raised its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 21.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,949 shares of the medical research compaMay 15, 2025 | marketbeat.comCaptrust Financial Advisors Grows Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Captrust Financial Advisors grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 648.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 5,730 shares of the medical research company's stock after buying an additional 4,964 shMay 15, 2025 | marketbeat.comBio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global ...May 12, 2025 | gurufocus.comBio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare ConferenceMay 12, 2025 | businesswire.comBank of America Corp DE Has $140.37 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Bank of America Corp DE increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 705.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 427,292 shares of the medical research company's stocMay 12, 2025 | marketbeat.comFirst Trust Advisors LP Lowers Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)First Trust Advisors LP cut its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 94.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,093 shares of the medical research company's stock afterMay 12, 2025 | marketbeat.comBalyasny Asset Management L.P. Invests $15.46 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Balyasny Asset Management L.P. purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 47,073 shares of the medical research company's stMay 11, 2025 | marketbeat.comClearline Capital LP Sells 12,244 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Clearline Capital LP decreased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 77.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,535 shares of the medical research company's stock after sellinMay 10, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Recommendation of "Moderate Buy" from AnalystsBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the five analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and three have given aMay 10, 2025 | marketbeat.comBio-Rad: With Low Debt And A Stock Price Drop, Is The Company Undervalued?May 9, 2025 | seekingalpha.comCaxton Associates LP Invests $590,000 in Bio-Rad Laboratories, Inc. (NYSE:BIO)Caxton Associates LP acquired a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,797 shares of the medical research company's stock, valMay 9, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by AQR Capital Management LLCAQR Capital Management LLC lessened its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 29,380 shares of the medical research company'sMay 9, 2025 | marketbeat.comNorthern Trust Corp Increases Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Northern Trust Corp raised its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 24.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 260,868 shares of the medical research company's stock after aMay 7, 2025 | marketbeat.comBellevue Group AG Sells 12,600 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Bellevue Group AG decreased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 27.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,551 shares of the medical reMay 6, 2025 | marketbeat.comTudor Investment Corp ET AL Invests $2.44 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Tudor Investment Corp ET AL acquired a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 7,433 shares of the medical research company's stock, valued at apMay 6, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 5.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,144 shares of the medicalMay 6, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Releases Earnings Results, Beats Expectations By $0.81 EPSBio-Rad Laboratories (NYSE:BIO - Get Free Report) issued its quarterly earnings data on Thursday. The medical research company reported $2.54 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.81. The firm had revenue of $585.40 million for the quarter, compared to analyst estimates of $573.01 million. Bio-Rad Laboratories had a negative net margin of 71.86% and a positive return on equity of 3.90%. The company's revenue for the quarter was down 4.2% on a year-over-year basis. During the same quarter last year, the firm earned $2.30 earnings per share.May 5, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Stock Holdings Raised by Ariel Investments LLCAriel Investments LLC grew its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 48.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 560,524 shares of the medical research company's stock after purchasMay 5, 2025 | marketbeat.comAYAL Capital Advisors Ltd Buys New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)AYAL Capital Advisors Ltd purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 13,600 shares of the medical researchMay 5, 2025 | marketbeat.comAnalysts Have Been Trimming Their Bio-Rad Laboratories, Inc. (NYSE:BIO) Price Target After Its Latest ReportMay 4, 2025 | uk.finance.yahoo.comFreestone Grove Partners LP Makes New $15.12 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)Freestone Grove Partners LP purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 46,015 shares of the medical research company's stock, valued at approximately $15,116,000. FreestoneMay 4, 2025 | marketbeat.comComerica Bank Increases Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Comerica Bank boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 8.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 59,775 shares of the medical research company's stock after acquiring an additional 4,609 shares during the period.May 4, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Purchases 20,413 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)The Manufacturers Life Insurance Company boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 23.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 107,195 shares of the medical research company's stock after purchasing anMay 4, 2025 | marketbeat.comMarshall Wace LLP Buys New Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Marshall Wace LLP purchased a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,279 shares of the medical research company's stock, valued at approxMay 4, 2025 | marketbeat.comTower Research Capital LLC TRC Sells 1,415 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Tower Research Capital LLC TRC lessened its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 54.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,167 shares of the medical researMay 3, 2025 | marketbeat.comBio-Rad Laboratories Inc (BIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...May 2, 2025 | gurufocus.comQ1 2025 Bio Rad Laboratories Inc Earnings Call TranscriptMay 2, 2025 | gurufocus.comBio-Rad Laboratories (BIO) Faces Revenue Challenges Amid Market HeadwindsMay 2, 2025 | gurufocus.comBio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comBio-Rad Reports First-Quarter 2025 Financial ResultsMay 1, 2025 | businesswire.comPerbak Capital Partners LLP Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)Perbak Capital Partners LLP bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 4,199 shares of the medical research company's stock, valuedMay 1, 2025 | marketbeat.comEarnest Partners LLC Buys 12,500 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Earnest Partners LLC grew its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 2.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 618,049 shares of the medical research company's stock aftApril 29, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by MML Investors Services LLCMML Investors Services LLC increased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 98.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,660 shares of the medical research company's stock afteApril 29, 2025 | marketbeat.comOneDigital Investment Advisors LLC Buys 2,492 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)OneDigital Investment Advisors LLC boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 379.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 3,149 shares of the medical research company's stock after purchasing an additional 2,492 shaApril 28, 2025 | marketbeat.comRaymond James Financial Inc. Acquires New Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Raymond James Financial Inc. bought a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 15,581 shares of the medical research company's stock, valuedApril 28, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Stock Price Down 5% - What's Next?Bio-Rad Laboratories (NYSE:BIO) Shares Down 5% - What's Next?April 27, 2025 | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Takes Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,641 shares of the medical resApril 27, 2025 | marketbeat.comBio-Rad Laboratories (BIO) to Release Quarterly Earnings on ThursdayBio-Rad Laboratories (NYSE:BIO) will be releasing its Q1 2025 earnings after the market closes on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-bio-rad-laboratories-inc-stock/)April 26, 2025 | marketbeat.comTeachers Retirement System of The State of Kentucky Cuts Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Teachers Retirement System of The State of Kentucky trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 6.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investoApril 24, 2025 | marketbeat.comDimensional Fund Advisors LP Grows Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Dimensional Fund Advisors LP boosted its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 14.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 746,119 shares of the medical research company's stock after buying an additionalApril 24, 2025 | marketbeat.comInvesco Ltd. Has $12.79 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Invesco Ltd. trimmed its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,944 shares of the medical research company's stock afteApril 23, 2025 | marketbeat.comDoes Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile?April 22, 2025 | insidermonkey.comBarclays PLC Sells 1,557 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Barclays PLC lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 40,419 shares of the medical research company's stock after sellingApril 22, 2025 | marketbeat.com Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address BIO Media Mentions By Week BIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼1.370.65▲Average Medical News Sentiment BIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼97▲BIO Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Charles River Laboratories International News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIO Stock Free BIO Stock Alerts